Placebo News and Research

RSS

Study results of a potential drug to treat Type 2 diabetes in children announced

Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal of Medicine also published the findings.

29 Apr 2019

Intensive blood pressure treatment benefits people with type 2 diabetes regardless of cardiovascular risk

People with type 2 diabetes who received intensive treatment to keep their blood pressure levels at 130/80 mm/Hg or below had fewer heart attacks, strokes and other diabetes complications, according to a study published in the American Heart Association's journal Hypertension.

29 Apr 2019

Peppermint oil helps people with non-cardiac chest pain and difficulty swallowing

Imagine that while eating a delicious meal at your favorite restaurant, your joy is cut short because of difficulty swallowing your food, followed by chest pain.

27 Apr 2019

FDA approves new treatment for children with lupus

The U.S. Food and Drug Administration today approved Benlysta (belimumab) intravenous infusion for treatment of children with systemic lupus erythematosus – often referred to as simply "lupus" – a serious chronic disease that causes inflammation and damage to various body tissues and organs.

27 Apr 2019

Peanut allergy tolerance treatment may increase the risk of anaphylaxis

Treating children who have a peanut allergy by gradually exposing them to increasing levels of peanut extract may actually increase their risk of allergic attacks, warn researchers.

26 Apr 2019

Psychologists study how application of cortisol affects exposure therapy for anxiety disorders

Bochum-based psychologists have studied how the application of the stress hormone cortisol affects exposure therapy for anxiety disorders.

25 Apr 2019

Using blood thinners in heart failure patients associated with reduced risk of thromboembolic events

Researchers at University of California San Diego School of Medicine found that using blood thinners in patients with worsening heart failure, coronary artery disease or irregular heart rhythms was associated with a 17 percent reduced risk of thromboembolic events, such as stroke and heart attack.

25 Apr 2019

FDA authorizes marketing of first medical device to treat ADHD

The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder.

22 Apr 2019

Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients

The commonly used diabetes drug metformin could reverse the harmful thickening of heart muscle that leads to cardiovascular disease, according to a study at the University of Dundee.

17 Apr 2019

Magic mouthwash effectively reduces mouth sore pain caused by radiation therapy

"Magic mouthwash," an oral rinse containing diphenhydramine, lidocaine and antacids, significantly reduced pain from oral mucositis, mouth sores, in patients receiving radiation therapy for cancers of the head and neck when compared to plaecbo.

16 Apr 2019

Drug lowers kidney failure risk in diabetic patients, study finds

A new landmark clinical trial shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.

15 Apr 2019

Rheumatoid arthritis patients likely to experience cardiovascular benefits from statins

Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks.

15 Apr 2019

Brain training to strengthen the brain's neural network

A new study reveals that less than an hour of training the brain could help strengthen the neural connections of the brain. This study could help develop new treatment and management strategies for progressive neurodegenerative disorders such as stroke and Parkinson’s believe the researchers.

15 Apr 2019

Less than one hour of brain training leads to strengthening of neural connections

Less than one hour of brain training with neurofeedback leads to a strengthening of neural connections and communication among brain areas.

15 Apr 2019

Improved gut diversity causes 50% reduction in autism symptoms

Changing the microbial environment in the gut in autistic children could substantially reduce the severity of the symptoms they experience, according to new research.

11 Apr 2019

Study sheds new light on long-term treatment with antidepressant drugs

A new study published in the current issue of Psychotherapy and Psychosomatics sheds new light on long-term studies with antidepressant drugs.

11 Apr 2019

Innovative drug delivery may alleviate Parkinson's symptoms and stop its progression

Parkinson's disease affects between 7 and 10 million people worldwide and the number of people diagnosed is soaring due to the ageing population.

10 Apr 2019

$FDA approves new osteoporosis drug for postmenopausal women with high fracture risk$

Placebo News and Research

Study results of a potential drug to treat Type 2 diabetes in children announced

Intensive blood pressure treatment benefits people with type 2 diabetes regardless of cardiovascular risk

Peppermint oil helps people with non-cardiac chest pain and difficulty swallowing

FDA approves new treatment for children with lupus

Peanut allergy tolerance treatment may increase the risk of anaphylaxis

Psychologists study how application of cortisol affects exposure therapy for anxiety disorders

Using blood thinners in heart failure patients associated with reduced risk of thromboembolic events

FDA authorizes marketing of first medical device to treat ADHD

Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients

Magic mouthwash effectively reduces mouth sore pain caused by radiation therapy

Drug lowers kidney failure risk in diabetic patients, study finds

Rheumatoid arthritis patients likely to experience cardiovascular benefits from statins

Brain training to strengthen the brain's neural network

Less than one hour of brain training leads to strengthening of neural connections

Improved gut diversity causes 50% reduction in autism symptoms

Study sheds new light on long-term treatment with antidepressant drugs

Innovative drug delivery may alleviate Parkinson's symptoms and stop its progression

FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

Acetaminophen can limit positive empathy for others, study shows

Anti-inflammatory medicine can be effective in treating people with depression

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News